GB873526A - Fluid compositions comprising (acetyl-salicylic acid)-anhydride - Google Patents

Fluid compositions comprising (acetyl-salicylic acid)-anhydride

Info

Publication number
GB873526A
GB873526A GB23544/58A GB2354458A GB873526A GB 873526 A GB873526 A GB 873526A GB 23544/58 A GB23544/58 A GB 23544/58A GB 2354458 A GB2354458 A GB 2354458A GB 873526 A GB873526 A GB 873526A
Authority
GB
United Kingdom
Prior art keywords
glycerine
ingredients
anhydride
propylene glycol
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23544/58A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB873526A publication Critical patent/GB873526A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

Abstract

A stable, fluid composition for oral use comprises (acetylsalicylic acid)-anhydride and a liquid carrier which may be glycerine, propylene glycol, a liquid polyalkylene glycol, a vegetable oil, e.g. coconut, cottonseed or sesame oils, 2,2-dimethyl-4-oxymethyl-1,3-dioxolane, N,N-dimethyl acetamide (preferred for solutions) or mixtures thereof which are miscible with each other and compatible with other ingredients. Anhydrous ethanol may also be present when compatible, e.g. with glycerine or propylene glycol. The water content of the vehicle should not exceed 5% by weight and preferably should not be more than 1%. Additional active ingredients, for example, acetophenetidin, caffeine, codeine, salicylamide, N - acetyl - p - aminophenol, cortisone, hydrocortisone or its derivatives, tranquilizers, sedatives, antihistaminics, anti-ussive agents, antibiotics and vitamins, especially ascorbic, pantothenic and p-aminobenzoic acids, may also be present. Other ingredients, for example, sweetening, suspending, demulcent, flavouring and surface-active agents, may also be added. The anhydride and other ingredients may be in particles of reduced size produced, for example, by milling to give particles of about 10 to 100 microns in size or by jet-pulverizing e.g. air-micronizing to give particles of under 10 microns. For suspensions, for which glycerine is the preferred vehicle, uniformity of the product may be assured, e.g. by passage through a colloid mill or homogenizing equipment. Examples given are suspensions in glycerine, glycerine and ethanol, polyethylene glycol, propylene glycol, coconut oil and cottonseed oil comprising also acetophenetidin, caffeine, codeine, hydrocortisone, phenobarbitol, benactyzine, tetracycline and b -ortho-methoxyphenylisopropyl methylamine and of a solution in N,N-dimethylacetamide.
GB23544/58A 1957-08-14 1958-07-22 Fluid compositions comprising (acetyl-salicylic acid)-anhydride Expired GB873526A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US873526XA 1957-08-14 1957-08-14

Publications (1)

Publication Number Publication Date
GB873526A true GB873526A (en) 1961-07-26

Family

ID=22204677

Family Applications (1)

Application Number Title Priority Date Filing Date
GB23544/58A Expired GB873526A (en) 1957-08-14 1958-07-22 Fluid compositions comprising (acetyl-salicylic acid)-anhydride

Country Status (1)

Country Link
GB (1) GB873526A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0856310A2 (en) * 1997-02-04 1998-08-05 Senju Pharmaceutical Co., Ltd. Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
GB2533669A (en) * 2014-12-23 2016-06-29 Innovate Pharmaceuticals Ltd Salicylate compound composition
US10010612B2 (en) 2007-05-25 2018-07-03 Indivior Uk Limited Sustained delivery formulations of risperidone compounds
US10022367B2 (en) 2014-03-10 2018-07-17 Indivior Uk Limited Sustained-release buprenorphine solutions
US10058554B2 (en) 2005-09-30 2018-08-28 Indivior Uk Limited Sustained release small molecule drug formulation
US10172849B2 (en) 2010-06-08 2019-01-08 Indivior Uk Limited Compositions comprising buprenorphine
US10198218B2 (en) 2010-06-08 2019-02-05 Indivior Uk Limited Injectable flowable composition comprising buprenorphine

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0856310A3 (en) * 1997-02-04 2000-01-19 Senju Pharmaceutical Co., Ltd. Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
EP1389469A1 (en) * 1997-02-04 2004-02-18 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US7320985B2 (en) 1997-02-04 2008-01-22 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
EP0856310A2 (en) * 1997-02-04 1998-08-05 Senju Pharmaceutical Co., Ltd. Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
US11110093B2 (en) 2005-09-30 2021-09-07 Indivior Uk Limited Sustained release small molecule drug formulation
US10058554B2 (en) 2005-09-30 2018-08-28 Indivior Uk Limited Sustained release small molecule drug formulation
US10376590B2 (en) 2007-05-25 2019-08-13 Indivior Uk Limited Sustained delivery formulations of risperidone compound
US11712475B2 (en) 2007-05-25 2023-08-01 Indivior Uk Limited Sustained delivery formulations of risperidone compound
US11013809B2 (en) 2007-05-25 2021-05-25 Indivior Uk Limited Sustained delivery formulations of risperidone compound
US10010612B2 (en) 2007-05-25 2018-07-03 Indivior Uk Limited Sustained delivery formulations of risperidone compounds
US10558394B2 (en) 2010-06-08 2020-02-11 Indivior Uk Limited Injectable flowable composition comprising buprenorphine
US10198218B2 (en) 2010-06-08 2019-02-05 Indivior Uk Limited Injectable flowable composition comprising buprenorphine
US10172849B2 (en) 2010-06-08 2019-01-08 Indivior Uk Limited Compositions comprising buprenorphine
US10592168B1 (en) 2010-06-08 2020-03-17 Indivior Uk Limited Injectable flowable composition comprising buprenorphine
US10517864B2 (en) 2014-03-10 2019-12-31 Indivior Uk Limited Sustained-release buprenorphine solutions
US10022367B2 (en) 2014-03-10 2018-07-17 Indivior Uk Limited Sustained-release buprenorphine solutions
GB2533669B (en) * 2014-12-23 2016-12-14 Innovate Pharmaceuticals Ltd Salicylate compound composition
AU2015370673B2 (en) * 2014-12-23 2021-06-03 Innovate Pharmaceuticals Limited Salicylate compound composition
WO2016102959A1 (en) * 2014-12-23 2016-06-30 Innovate Pharmaceuticals Limited Salicylate compound composition
US11129837B2 (en) 2014-12-23 2021-09-28 Innovate Pharmaceuticals Limited Salicylate compound composition
GB2533669A (en) * 2014-12-23 2016-06-29 Innovate Pharmaceuticals Ltd Salicylate compound composition

Similar Documents

Publication Publication Date Title
US3981996A (en) Pharmaceutical skin compositions
KR900015741A (en) Pharmaceutical composition
US3636200A (en) Pharmaceutical suspension
RU2224505C2 (en) Utilizing nanodispersions in compositions for pharmaceutical application
GB1333475A (en) Cosmetic compositions
KR840006437A (en) Method of Preparation of Formulation for Oral Antibiotic Administration
JPS5637040A (en) Oil-in-polyhydric alcohol type emulsifying composition
IE34751B1 (en) Liquid detergent compositions
GB873526A (en) Fluid compositions comprising (acetyl-salicylic acid)-anhydride
JPS5659710A (en) Preventive and remedy for psoriasis
GB1341937A (en) Liquid detergent compositions containing olefin sulphonates
ES2171525T3 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING PROPIONIC ACID (S) -2- (4-ISOBUTILFENIL).
KR910016333A (en) Process for the preparation of the pyroxicam / cyclodextrin complex, the product obtained thereby and the pharmaceutical composition thereof
IE31848B1 (en) Liquid dentifrices containing abrasives
KR900005990A (en) Psyllium-containing products
IE35811L (en) Triazolo diazepines
IT1140529B (en) COMPOSITIONS TO BE USED AS COSMETICS AND PROCEDURE FOR THE PREPARATION OF THEIR ACTIVE INGREDIENTS
US2773835A (en) Liquid shampoo composition
NO962129D0 (en) New pharmaceutical composition for the preparation of a stable powder containing an active principle comprising a compound of acetylsalicylic acid and metoclopramide
US3024165A (en) Effervescent acetyl-salicylic acid tablet
SE8304062L (en) NEW DICLORATED DERIVATIVES OF THE 16ALFA-METHYL PREGNANCY SERIES, PREPARATION thereof, USE THEREOF AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM
ES8102803A1 (en) Microporous Bodies having Occluded Agents
JPS5731614A (en) Lipid improver
US3888798A (en) Liquid detergent composition
US3077438A (en) Stabilization of orally administrable methenamine mandelate sesame oil suspensions containing 12-hydroxy stearic acid triglyceride